The effects of increasing obesity on outcomes of vascular surgery

Nader Khandanpour1, Matthew P Armon, Rob Foxall

  • 1Vascular Surgery Department, Norfolk and Norwich Vascular Unit, Norfolk and Norwich University Hospital, Norwich, UK. nkh950@yahoo.com

Insights

Vascular surgery patients are increasingly obese. Morbidly obese patients experience longer operation times and higher infection rates, particularly for abdominal aortic aneurysm repair, though overall outcomes remain similar in this study.

Area of Science:

  • Vascular Surgery
  • Obesity Research
  • Surgical Outcomes

Background:

  • Increasing prevalence of obesity in the general population.
  • Potential impact of rising obesity rates on vascular surgery patient demographics and outcomes.

Purpose of the Study:

  • To investigate the trend of increasing obesity among vascular surgery patients.
  • To determine if morbid obesity (BMI > 35 kg/m2) affects surgical outcomes, including operation duration, length of stay, complications, and mortality.

Main Methods:

  • Retrospective analysis of 1,105 vascular procedures (infrainguinal bypass, carotid endarterectomy, AAA repair) from 1996-2006.
  • Patients stratified by Body Mass Index (BMI): underweight (<18.5), morbidly obese (>35), and control (18.5-35).
  • Outcomes adjusted for confounding variables (admission mode, diabetes, cardiac history, renal function, smoking).

Main Results:

  • Incidence of morbid obesity in vascular patients increased linearly from 1.3% to 9% over 10 years.
  • Morbidly obese patients had significantly longer operation durations for AAA repair (189.8 vs. 158.4 min, p < 0.014).
  • Higher infection rates observed in morbidly obese patients, significantly so for AAA repair (43.5% vs. 34.8%, p < 0.004).

Conclusions:

  • Vascular surgery patient population is experiencing a progressive increase in obesity.
  • Morbid obesity is associated with increased operative time and infectious complications, particularly in AAA repair.
  • Despite these challenges, morbid obesity did not significantly worsen overall surgical outcomes or mortality in this cohort.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...